Farmmi Inc

Farmmi Inc (FAMI) Stock Analysis

$0.093

+0.003 (+2.88%)At close

Loading chart…
High
0.098
Open
0.096
VWAP
0.09
Volume
2.14M
Mkt Cap
4.70M
Low
0.092
Amount
201.19K
EV/EBITDA, TTM
0.00

Farmmi Inc is a holding company principally engaged in the processing and sales of a variety of mushrooms, edible fungi and other agricultural products. The Company’s main products include edible fungi (edible mushroom), shiitake, Mu Er, bamboo fungi, agrocybe aegerila, pleurotus eryngii, grifola frondosa and other agricultural products such as crab, orange, rice and others. The Company distributes products under brand Lishui Shangeng, Farmmi Liangpin, Forasen, and others. The Company distributes products in the domestic and overseas markets, including the U.S., Japan, Canada, and other countries or regions.

farmmi.com

AI analysis of Farmmi Inc (FAMI)

Sell

Farmmi Inc is not a good buy right now due to its significant financial struggles and negative market sentiment. The stock has a current price of $0.09, which is near its 52-week low of $0.09, and it has experienced a staggering year-to-date change of -92.79%. Additionally, the company's forward P/E ratio is 0, indicating no expected earnings growth, and it recently completed a public offering at a 79% discount, which has raised concerns about its financial health. The main risk is the company's substantial net loss of $53.4 million for the fiscal year ending September 30, 2025, alongside a revenue decline of over 56%.

Valuation Metrics

The current forward P/E ratio for Farmmi Inc (FAMI) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
Overvalued
0.00
Undervalued
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued
0.00
Undervalued
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
Overvalued
0.00
Undervalued
0.00

Alphio AI Price Scenarios for FAMI

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%FAMI

$1.91

Scenario price

B

Base

Base · 50%FAMI

$1.68

Scenario price

B

Bear

Bear · 25%FAMI

$1.45

Scenario price

Events Timeline

2026-08-04 (ET)

17:30:00

Farmmi Signs Acquisition Agreement to Acquire 100% Equity of Four Seasons Holding Group

2026-06-29 (ET)

08:00:00

Farmmi Prices Public Offering Expected to Raise $3M

2026-03-11 (ET)

07:10:00

Farmmi Subsidiary Receives Hazardous Materials Permit in California

2026-01-26 (ET)

07:10:00

Farmmi Establishes Wholly-Owned Subsidiary Bluesage Marketing for Digital Marketing

2026-01-14 (ET)

07:10:00

Farmmi Subsidiary Achieves FDA Food Facility Registration

News

FAMI FAQ — answered by Alphio AI

Farmmi Inc is a holding company principally engaged in the processing and sales of a variety of mushrooms, edible fungi and other agricultural products. The Company’s main products include edible fungi (edible mushroom), shiitake, Mu Er, bamboo fungi, agrocybe aegerila, pleurotus eryngii, grifola frondosa and other agricultural products such as crab, orange, rice and others. The Company distributes products under brand Lishui Shangeng, Farmmi Liangpin, Forasen, and others. The Company distributes products in the domestic and overseas markets, including the U.S., Japan, Canada, and other countries or regions. It operates in the Consumer Non-Cyclicals sector (CANNED FRUITS, VEGETABLES, PRESERVES, JAMS, AND JE industry).

Farmmi Inc is not a good buy right now due to its significant financial struggles and negative market sentiment. The stock has a current price of $0.09, which is near its 52-week low of $0.09, and it has experienced a staggering year-to-date change of -92.79%. Additionally, the company's forward P/E ratio is 0, indicating no expected earnings growth, and it recently completed a public offering at a 79% discount, which has raised concerns about its financial health. The main risk is the company's substantial net loss of $53.4 million for the fiscal year ending September 30, 2025, alongside a revenue decline of over 56%.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading